NCT04430322

Brief Summary

France and especially the region "Grand Est" have been damaged by the COVID-19 pandemic. This pandemic resulted in a reorganization of the hospitalization sectors. In order to better understand the disease, the investigators wish to carry out a descriptive analysis of hospitalized patient data. This study would notably allow us to identify some prognostic factors. The main objective of this study is to identify individual factors that are associated with a poor prognosis (with ICU admission or death).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,045

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2020

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

June 11, 2020

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 12, 2020

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2022

Completed
Last Updated

August 29, 2023

Status Verified

August 1, 2022

Enrollment Period

2.3 years

First QC Date

June 11, 2020

Last Update Submit

August 28, 2023

Conditions

COVID

Outcome Measures

Primary Outcomes (1)

  • ICU admission

    Number of ICU admission during the hospitalization

    Day 1

Secondary Outcomes (19)

  • Hospitalization

    Day 1

  • Length of stay at the ICU

    Day 1

  • Death

    Day 1

  • CT scan result

    Day 1

  • C reactive protein

    Day 1

  • +14 more secondary outcomes

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient hospitalized in COVID Unit at the Regional Hospital Center Metz-Thionville during the COVID-19 pandemic with a PCR positive or COVID confirmed with clinical evidence and CT scan.

You may qualify if:

  • Patient hospitalized in COVID Unit at the Regional Hospital Center Metz-Thionville during the COVID 19 pandemic
  • PCR positive or COVID confirmed with clinical evidence and CT scan

You may not qualify if:

  • Patients not willing to participate via using their medical files
  • Patient transferred after a brief stay in another hospital

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHR Metz Thionville

Metz, 57085, France

Location

Related Publications (1)

  • Louis G, Dinot V, Belveyre T, Dirand O, Dunand P, Cadoz C, Gaci R, Gette S, Perez P, Goetz C, Picard Y, Mellati N. Comparison of fully-vaccinated and non/partially-vaccinated critically-ill COVID-19 patients in terms of disease severity: a retrospective observational study. BMC Infect Dis. 2025 Oct 31;25(1):1457. doi: 10.1186/s12879-025-11904-4.

    PMID: 41174545DERIVED

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 11, 2020

First Posted

June 12, 2020

Study Start

March 1, 2020

Primary Completion

June 1, 2022

Study Completion

June 1, 2022

Last Updated

August 29, 2023

Record last verified: 2022-08

Locations

FR(1)